Nevertheless, taking into consideration all tested cytokines, the obtained data suggests that BMDC-based vaccines are significantly more potent in induction of Th1-type response when TGF-β1 concentration in tumor microenvironment is reduced. The gene discussed is TGFB1; the disease is neoplasm.